Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment
- PMID: 20971585
- DOI: 10.1016/j.drugalcdep.2010.09.013
Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment
Abstract
This is a register-based cohort study of 20,581 individuals in treatment for illicit substance use disorders in Denmark between 1996 and 2006. All in all, 1441 deaths were recorded during 111,445 person-years of follow-up. Standardized mortality ratios (SMRs) associated with different primary substance types were calculated and Cox-regression analyses were performed in order to establish hazard ratios (HR) associated with injection drug use and psychiatric comorbidity. SMRs for primary users of specific substances were: cannabis: 4.9 (95% confidence interval (CI): 4.2-5.8), cocaine: 6.4 (CI: 3.9-10.0), amphetamine: 6.0 (CI: 4.2-8.3), heroin: 9.1 (CI: 8.5-9.8), and other opioids 7.7 (CI: 6.6-8.9). For MDMA ('ecstasy') the crude mortality rate was 1.7/1000 person-years (CI: 0.4-7.0) and the SMR was not significantly elevated. Injection drug use was associated with significantly increased hazard ratios in users of opioids and cocaine/amphetamine. Overall, psychiatric comorbidity was not associated with increased mortality (HR: 1.1 [CI: 0.9-1.2], p=.28), but an association was found specifically among cocaine/amphetamine users (HR: 3.6 [CI: 2.1-6.4], p<.001).
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Mortality following treatment for cannabis use disorders: predictors and causes.J Subst Abuse Treat. 2013 Apr;44(4):400-6. doi: 10.1016/j.jsat.2012.09.007. Epub 2012 Nov 2. J Subst Abuse Treat. 2013. PMID: 23122774
-
Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.J Subst Abuse Treat. 2007 Mar;32(2):113-9. doi: 10.1016/j.jsat.2006.07.005. Epub 2006 Oct 27. J Subst Abuse Treat. 2007. PMID: 17306720
-
[Narcotic abuse in Jylland. A study based on narcotics and deaths of addicts examined at the Institute of Forensic Medicine, University of Aarhus during the period 1981-1988. 1. Narcotics].Ugeskr Laeger. 1990 Apr 9;152(15):1077-80. Ugeskr Laeger. 1990. PMID: 2330627 Danish.
-
MDMA: interactions with other psychoactive drugs.Pharmacol Biochem Behav. 2011 Oct;99(4):759-74. doi: 10.1016/j.pbb.2011.06.032. Epub 2011 Jul 5. Pharmacol Biochem Behav. 2011. PMID: 21756931 Review.
-
[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].Fortschr Neurol Psychiatr. 2004 Dec;72(12):679-95. doi: 10.1055/s-2004-818531. Fortschr Neurol Psychiatr. 2004. PMID: 15580533 Review. German.
Cited by
-
Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment.Drug Alcohol Depend. 2019 Feb 1;195:164-169. doi: 10.1016/j.drugalcdep.2018.06.036. Epub 2018 Nov 11. Drug Alcohol Depend. 2019. PMID: 30429048 Free PMC article.
-
Age, period and cohort trends in drug abuse hospitalizations within the total Swedish population (1975-2010).Drug Alcohol Depend. 2014 Jan 1;134:355-361. doi: 10.1016/j.drugalcdep.2013.11.011. Epub 2013 Nov 19. Drug Alcohol Depend. 2014. PMID: 24300899 Free PMC article.
-
Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.Addiction. 2015 Jan;110(1):129-43. doi: 10.1111/add.12754. Addiction. 2015. PMID: 25291977 Free PMC article. Clinical Trial.
-
No decline in drug overdose deaths in Norway: An ecological approach to understanding at-risk groups and the impact of interventions.Nordisk Alkohol Nark. 2024 Feb;41(1):111-130. doi: 10.1177/14550725231195413. Epub 2023 Sep 28. Nordisk Alkohol Nark. 2024. PMID: 38356787 Free PMC article.
-
Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder.PLoS One. 2018 Aug 23;13(8):e0202028. doi: 10.1371/journal.pone.0202028. eCollection 2018. PLoS One. 2018. PMID: 30138449 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical